Towards a ‘Human‐like’ Model of Tuberculosis: Intranasal Inoculation of LPS Induces Intragranulomatous Lung Necrosis in Mice Infected Aerogenically with Mycobacterium tuberculosis

It is well known that one of the differences between murine and human tuberculosis is the lack of intragranulomatous necrosis in the former. The aim of this study was to create a feasible and reproducible model of an experimental model of murine tuberculosis in which this necrosis should be present. Considering the Shwartzman reaction as a possible explanation for intragranulomatous necrosis in human tuberculosis, C57Bl/6 mice, infected aerogenically with a virulent strain of Mycobacterium tuberculosis, were intranasally inoculated with lipopolysaccharide (LPS) on day 19 postinfection (p.i.). Twenty‐four hours later, neutrophils infiltrated the lung parenchyma in a significant level, and 10 days after necrosis could be detected in the centres of primary granulomas, that showed scanty macrophages and large amounts of collagen on an eosinophilic background. On the other hand, a significant decrease in the concentration of colony forming units (CFU) could be appreciated 24 h after the LPS inoculation. Afterwards, nonbronchogenic spreading of granulomas increased and higher levels of interferon (IFN)‐γ mRNA were detected. These results lend support to the Shwartzman reaction as the origin of the intragranulomatous necrosis in the M. tuberculosis infection, and provides a useful tool to improve experimental murine models in tuberculosis.

[1]  Ariza,et al.  The Intravenous Model of Murine Tuberculosis is Less Pathogenic Than the Aerogenic Model Owing to a More Rapid Induction of Systemic Immunity , 1999, Scandinavian journal of immunology.

[2]  J. Blackwell,et al.  Macrophage activation: lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, and tumor necrosis factor-alpha. , 1993, Journal of immunology.

[3]  I. Orme,et al.  Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.

[4]  Matthias Abend,et al.  Tuberculosis: Pathogenesis, Protection and Control , 1996, Nature Medicine.

[5]  M. Chignard,et al.  Effects of rolipram on cyclic AMP levels in alveolar macrophages and lipopolysaccharide‐induced inflammation in mouse lung , 1998, British journal of pharmacology.

[6]  J. Dannenberg.  Rabbit Model of Tuberculosis , 1994 .

[7]  H. Schreiber,et al.  Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[8]  F. Finkelman,et al.  Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. , 1991, Journal of immunology.

[9]  D. Smith,et al.  Host-parasite relationships in experimental airborne tuberculosis. IV. Early events in the course of infection in vaccinated and nonvaccinated guinea pigs. , 1970, The American review of respiratory disease.

[10]  R. Sobel,et al.  Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. , 1997, Journal of immunology.

[11]  I. Orme,et al.  Materials and Methods Briefdefinitive Report Disseminated Tuberculosis in Interferon 7 Gene-disrupted Mice , 2022 .

[12]  Lesley J. Murray,et al.  In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp‐lpr/lpr mouse , 1990, European journal of immunology.

[13]  A. Sher,et al.  Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. , 1993, Journal of immunology.

[14]  A. Ariza,et al.  Evolution of granulomas in lungs of mice infected aerogenically with Mycobacterium tuberculosis. , 2000, Scandinavian journal of immunology.

[15]  I. Orme.  Immunity to mycobacteria. , 1995, Current opinion in immunology.

[16]  Andersen,et al.  Analysis of T cells recruited during delayed‐type hypersensitivity to purified protein derivative (PPD) versus challenge with tuberculosis infection , 1998, Immunology.

[17]  I. Orme.  Cellular and genetic mechanisms underlying susceptibility of animal models to tuberculosis infection. , 1998, Novartis Foundation symposium.

[18]  I. Orme.  Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines , 1988, Infection and immunity.

[19]  T. Ulich,et al.  The intratracheal administration of endotoxin and cytokines. I. Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1-, and TNF-induced inflammatory infiltrate. , 1991, The American journal of pathology.

[20]  A. Dannenberg.  Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. , 1991, Immunology today.

[21]  R. H. Smith,et al.  A murine model of pulmonary damage induced by lipopolysaccharide via intranasal instillation. , 1997, Journal of immunological methods.

[22]  G. Comstock,et al.  A COMPARISON IN THE UNITED STATES OF AMERICA OF TWO TUBERCULINS, PPD-S AND RT 23. , 1964, Bulletin of the World Health Organization.

[23]  S. Weiss.  Tissue destruction by neutrophils. , 1989, The New England journal of medicine.

[24]  G. Rook,et al.  Cytokines and the Koch phenomenon. , 1991, Tubercle.

[25]  S. Sulavik,et al.  Resistance to Tuberculosis: Experimental Studies in Native and Acquired Defensive Mechanisms , 1966, The Yale Journal of Biology and Medicine.

[26]  M. B. Lurie.  THE CORRELATION BETWEEN THE HISTOLOGICAL CHANGES AND THE FATE OF LIVING TUBERCLE BACILLI IN THE ORGANS OF TUBERCULOUS RABBITS , 1932, The Journal of experimental medicine.

[27]  M. B. Lurie,et al.  Host-parasite relationships in natively resistant and susceptible rabbits on quantitative inhalation of tubercle bacilli. Their significance for the nature of genetic resistance. , 1962, The American review of respiratory disease.

[28]  D. Remick,et al.  Intratracheal administration of endotoxin and cytokines. IV. The soluble tumor necrosis factor receptor type I inhibits acute inflammation. , 1993, The American journal of pathology.